Maricel Apuli
Chief Accounting Officer at BridgeBio Pharma, Inc. (BBIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $622K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 3SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 2,000127,401 held (−2%) | $80.06 | $160K | -18.4% |
| May 4SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 2,000134,115 held (−1%) | $71.58 | $143K | -8.7% |
| Feb 27SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 2,000121,945 held (−2%) | $66.00 | $132K | -1.0% |
| Feb 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 510123,945 held (−0%) | $74.31 | $38K | -12.1% |
| Dec 10SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 2,000130,297 held (−2%) | $74.26 | $149K | -12.0% |
- Sell
Chief Accounting Officer Maricel Apuli sold $160K of BBIO at $80.06 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Maricel Apuli sold $143K of BBIO at $71.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Maricel Apuli sold $132K of BBIO at $66.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Maricel Apuli sold $38K of BBIO at $74.31 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Maricel Apuli sold $149K of BBIO at $74.26 — pre-scheduled 10b5-1 plan sale.